Abstract
The fate of patients with potentially resectable carcinomas is not only determined by the pTNM tumor stage, but also possibly by tumor-biological factors. The aim of this study was to identify these prognostic factors in patients undergoing primary curative (R0) resection. The study retrospectively analyzed 113 patients with ductal adenocarcinoma who were operated on between 1986 and 1995. R0 resection was able to be performed in 93 patients. Lymph node metastases were found in 73%. The rates of lymph vessel and perineural invasion were 83.5% and 45%, respectively. Among the 25 carcinomas without lymph node metastases, 64% already had lymph vessel invasion and 48% had perineural invasion. The cumulative 5-year survival rate of the 91 surviving patients analyzed was 10.5%. Depending on the tumor stage we found a significant difference in 5-year survival rates between patients without lymph node metastases (26.5%) and those with lymph node involvement (5%) (P 5 0.008). A multivariate analysis only identified lymph vessel invasion (L0/1), tumor size (≦/≦2 cm), and tumor grading (G) to have significant and independent prognostic value. Lymph vessel invasion, tumor size, and tumor grading proved to be independent factors determining long-term prognosis.
Similar content being viewed by others
References
Furukawa H, Okada S, Saisho H, Ariyama J, Karasawa E, Nakaizumi A, Nakazawa S, Murakami K, Kakizoe T (1996) Clinicopathologic features of small pancreatic adenocarcinoma. Cancer 78:986–990
Hermanek P (1998) Pathology and biology of pancreatic ductal adenocarcinoma. Langenbeck’s Arch Surg 383:116–120
Lüttges J, Vogel I, Menke M, Henne-Bruns D, Kremer B, Klöppel G (1998) The retroperitoneal resection margin and vessel involvement are important factors determining the survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch 433:237–242
Henne-Bruns D, Kremer B (1998) Aspekte der chirurgischen Therapie des duktalen Pankreaskarzinoms. Viszeralchirurgie 33: 211–216
Satake K, Nishiwaki H, Yokomatsu H, Kawazoe Y, Kim K, Haku A, Umeyama K, Miyazaki I (1992) Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet 175:259–265
Sobin LH, Wittekind Ch (1997) TNM Classification of malignant tumours 5th edn. Wiley, New York, p 90
Geer RJ, Brennan MF (1993) Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 217: 144–148
Klempnauer J, Ridder GJ, Bektas H, Pichlmayr R (1995) Möglichkeiten und Grenzen der kurativen Resektion beim duktalen Pankreaskarzinom. Akt Chir 30:237–241
Yamamoto M, Saitoh Y, Hermanek P (1995) Exocrine pancreatic carcinoma. In: Hermanek P, Gospodarowicz MK, Henson DE et al. (eds) Prognostic factors in cancer. Springer, Berlin Heidelberg New York, pp 103–117
Gall FP, Kessler H, Hermanek P (1991) Surgical treatment of ductal pancreatic carcinoma. Eur J Surg Oncol 17:173–181
Yeo CHJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, Dooley WC, Coleman J, Pitt HA (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas, 201 patients. Ann Surg 221:721–733
Beger HG, Büchler MW, Friess H (1994) Chirurgische Ergebnisse und Indikationen zu adjuvanten Maßnahmen beim Pankreaskarzinom. Chirurg 65:246–252
Höfler H (1994) Prognosefaktoren beim Pankreaskarzinom. Chirurg 65:253–257
Reich O, Justus J (1991) Zum biologischen Verhalten des exokrinen Pankreaskarzinoms aus pathologisch-anatomischer Sicht. Zent bl Chir 116:1333–1340
Yeo CJ, Cameron JL (1998) Prognostic factors in ductal pancreatic carcinoma. Langenbeck’s Arch Surg 383:129–133
Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boitnott JK, Seidler AJ, Coleman J (1991) Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 161:120–125
Nitecki SS, Sarr MG, Colby TV, van Heerden JA (1995) Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221:59–66
Nagakawa T, Ohta T, Kayahara M (1997) Extended radical pancreatoduodenectomy for carcinoma of the head of the pancreas. In: Hanyu F, Takasaki K (eds) Pancreatoduodenectomy. Springer, Berlin Heidelberg New York Tokyo, pp 151–164
Report of the “Pancreas Club Meeting” (1998) May 11, 1997. Am J Surg 175:172–178
Böttger TC, Störkel S, Wellek S, Stöckle M, Junginger T (1994) Factors influencing survival after resection of pancreatic cancer: Cancer 73:63–73
Klöppel G, Lohse T, Bosselt K, Rückert K (1987) Ductal adenocarcinoma of the head of the pancreas: incidence of tumor involvement beyond the Whipple resection line; histological and immunocytochemical analysis of 37 total pancreatectomy specimens. Pancreas 2:170–175
Ihse I, Anderson H, Andrén-Sandberg A (1996) Total pancreatectomy for cancer of the pancreas: is it appropriate? World J Surg 20:288–294
Pancreatic Cancer Registration Committee of the Japan Pancreas Society (1993) Annual report of registered cases of pancreatic cancer in Japan (in Japanese). Japan Pancreas Society, Tokyo
Delcore R, Rodriguez FJ, Forster J, Hermreck AS, Thomas JH (1996) Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection. Am J Surg 172: 463–469
Ishikawa O, Ohigashi H, Sasaki Y, Kabuto T, Fukuda I, Furukawa H, Imaoka S, Iwanaga T (1988) Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 208:215–220
Nakasako T, Hanyu F, Takasaki K, Imaizumi T, Harada N, Hatori T, Fukuda A (1997) Indications for extended radical and pylorus preserving Whipple operation for pancreatic cancer. In: Hanyu F, Takasaki K (eds) Pancreatoduodenectomy. Springer, Berlin Heidelberg New York Tokyo, pp 99–106
Baumel H, Huguier M, Manderscheid JC, Farbe JM, Houry S, Fagot H (1994) Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg 81:102–110
Trede M, Saeger HD, Schwall G, Rumstadt B (1998) Resection of pancreatic cancer—surgical achievements. Langenbeck’s Arch Surg 383:121–128
Fortner JG, Klimstra DS, Senie RT, Maclean B (1996) Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg 223:147–153
Johnstone PA, Sindelar WF (1993) Lymph node involvement and pancreatic resection: correlation with prognosis and local disease control in a clinical trial. Pancreas 8:535–539
Tsuchiya R, Noda T, Harada N, Miyamoto T, Tomioka T, Yamamoto K, Yamaguchi T, Izawa K, Tsunoda T, Yoshino R, Eto T (1996) Collective review of small carcinomas of the pancreas. Ann Surg 203:77–81
Nagai H, Kuroda A, Morioka Y (1986) Lymphatic and local spread of T1 and T2 pancreas cancer: a study of autopsy material. Ann Surg 204:65–71
Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I (1993) An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 72:2118–2123
Manabe T, Mashita K, Takeyama H, Tanaka M, Okada Y, Imamura M (1997) Pancreatectomy for small carcinoma of the head of the pancreas. In: Hanyu F, Takasaki K (eds) Pancreatoduodenectomy. Springer, Berlin Heidelberg New York Tokyo, pp 85–91
Japan Pancreas Society (1996) Classification of pancreatic cancer. First English edition. Kanehara, Tokyo
Nakayama T, Kinoshita H, Saitsu H, Imayama H, Okuda K, Hara M, Fukuda S, Saitoh N (1997) Surgical results of pancreatoduodenectomy for disease in the pancreatic head region. In: Hanyu F, Takasaki K (eds) Pancreatoduodenectomy. Springer, Berlin Heidelberg New York Tokyo, pp 93–98
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meyer, W., Jurowich, C., Reichel, M. et al. Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas. Surg Today 30, 582–587 (2000). https://doi.org/10.1007/s005950070096
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s005950070096